What Is a Histiocytoma and How Is It Treated?

A histiocytoma is a common, non-threatening skin tumor primarily seen in dogs. This benign mass originates from Langerhans cells, a type of immune cell within the skin. Although the tumor grows rapidly, histiocytomas are known for their tendency to disappear naturally. Understanding the nature of this tumor, its diagnosis, and its typical outcome provides reassurance for owners.

Defining the Histiocytoma

A histiocytoma is a benign neoplasm arising from Langerhans cells, which are immune cells in the epidermis. These cells function as antigen-presenting cells, linking the innate and adaptive immune systems. The tumor represents a transient, uncontrolled proliferation of these cells.

Physically, a histiocytoma typically presents as a solitary, firm, raised mass, often described as dome-shaped or “button-like.” The surface is frequently red and hairless, but it may become ulcerated and irritated due to rapid growth or self-trauma. Most histiocytomas remain relatively small, generally measuring less than four centimeters in diameter.

The distinguishing biological feature of a histiocytoma is its capacity for spontaneous regression. The dog’s immune system recognizes the proliferating Langerhans cells as foreign. The tumor then becomes heavily infiltrated with T-lymphocytes, which actively destroy the tumor cells, leading to its eventual shrinkage and complete resolution over time.

It is important to distinguish this benign tumor from the much more aggressive counterpart, histiocytic sarcoma. While both originate from cells in the histiocyte family, the benign histiocytoma remains localized and resolves, whereas histiocytic sarcoma is a malignant tumor that can be disseminated throughout the body and carries a poor prognosis.

Who is Affected and Where They Appear

Histiocytomas overwhelmingly affect young dogs, with most cases occurring in animals under three years of age. They are the most common skin tumor seen in dogs less than one year old. If the tumor appears in a mature or older dog, increased diagnostic scrutiny is warranted to rule out other, more concerning masses.

The lesions can develop anywhere, but they are most frequently located on the head (including the pinnae), neck, and limbs. They are also often found on the trunk, typically the front half of the body. Certain breeds have a predisposition for developing these tumors:

  • Labrador Retrievers
  • Boxers
  • Dachshunds
  • Cocker Spaniels
  • Boston Terriers

Diagnostic Procedures

A veterinarian often suspects a histiocytoma based on the mass’s characteristic appearance and the dog’s age. However, a definitive diagnosis is necessary to differentiate the benign tumor from other masses, such as mast cell tumors or malignant histiocytic diseases, which require immediate, aggressive treatment.

The primary diagnostic tool is Fine Needle Aspiration (FNA) followed by cytology. This procedure involves inserting a small needle into the mass to collect a sample of cells for microscopic examination. On cytology, a histiocytoma typically shows sheets of large, round histiocytic cells with abundant cytoplasm.

As the tumor begins to regress, the cytology slides show an increasing number of small lymphocytes intermixed with the histiocytic cells, indicating the immune response. Although histiocytomas are benign, the cells can sometimes display features associated with malignancy. Therefore, the characteristic cell type and the presence of inflammatory cells are used in combination to confirm the diagnosis.

Treatment and Expected Outcome

The preferred management strategy for a confirmed histiocytoma is “watchful waiting.” Since the tumor’s regression is induced by the immune system, intervention is often unnecessary and may be counterproductive. Spontaneous regression typically begins within one to two months and is often complete within three months of the mass appearing.

The body’s T-lymphocytes infiltrate the mass, causing inflammation and the destruction of the tumor cells, a process that is usually successful. Surgical removal is generally reserved for specific circumstances:

  • The mass is ulcerated, infected, or causing significant discomfort to the dog.
  • The tumor has not shown any signs of regression after three months.
  • The initial diagnosis was ambiguous and requires a more thorough tissue biopsy.

Once a benign cutaneous histiocytoma is confirmed, the prognosis is excellent, regardless of whether it regresses naturally or is removed surgically. Recurrence is rare, and the mass does not pose a threat to the dog’s overall health. Managing the tumor often involves preventing the dog from irritating the area, such as with an Elizabethan collar, until the immune system completes its work.

Catalina Fernandez

Animal welfare science is Catalina Fernandez's field. She completed a PhD in animal behavior at the University of California, Davis, and over 12 years has measured stress, enrichment and housing effects in laying hens, dairy calves and shelter dogs. She now holds a faculty post in an animal science department and advises on farm welfare audit standards. Her writing covers the welfare of farm and companion animals, behavior science, and how researchers assess what animals experience.